Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathway.
D001241:Aspirin / Q000494:pharmacology; D001760:Bleeding Time; D006493:Heparin / Q000494:pharmacology*; D006494:Heparin Antagonists / Q000494:pharmacology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011466:Prostanoic Acids / Q000494:pharmacology; D013931:Thromboxanes / Q000037:antagonists & inhibitors*
D006494:Heparin Antagonists; D011466:Prostanoic Acids; D013931:Thromboxanes; C022574:13-azaprostanoic acid; D006493:Heparin; D001241:Aspirin; D007213:Indomethacin